Barclays analyst Stephanie Davis raised the firm’s price target on Labcorp to $249 from $213 and keeps an Equal Weight rating on the shares. The company reported a “better than feared” Q2 that featured a headline beat, raised revenue growth guidance, and updated earnings for the stronger print and expected Invitae dilution, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LH: